Cargando…

Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes

The effect Helicobacter pylori (Hp) infection and small intestinal bacterial over growth (SIBO) in minimal hepatic encephalopathy (MHE) is not well understood. The aim of the study was to determine the effect of eradication of Hp infection and SIBO treatment on MHE in patients with cirrhosis. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Abid, Shahab, Kamran, Muhammad, Abid, Adeel, Butt, Nazish, Awan, Safia, Abbas, Zaigham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308324/
https://www.ncbi.nlm.nih.gov/pubmed/32572109
http://dx.doi.org/10.1038/s41598-020-67171-7
_version_ 1783548966691930112
author Abid, Shahab
Kamran, Muhammad
Abid, Adeel
Butt, Nazish
Awan, Safia
Abbas, Zaigham
author_facet Abid, Shahab
Kamran, Muhammad
Abid, Adeel
Butt, Nazish
Awan, Safia
Abbas, Zaigham
author_sort Abid, Shahab
collection PubMed
description The effect Helicobacter pylori (Hp) infection and small intestinal bacterial over growth (SIBO) in minimal hepatic encephalopathy (MHE) is not well understood. The aim of the study was to determine the effect of eradication of Hp infection and SIBO treatment on MHE in patients with cirrhosis. Patients with cirrhosis were enrolled and MHE was determined by psychometric tests and critical flicker frequency analysis. Hp infection and SIBO were assessed by urea breath and Hydrogen breath tests respectively in patients with cirrhosis and in healthy volunteers. Patients with Hp infection and SIBO were given appropriate treatment. At six weeks follow-up, presence of Hp infection, SIBO and MHE status was reassessed. Ninety patients with cirrhosis and equal number of healthy controls were included. 55 (61.1%) patients in the cirrhotic group were diagnosed to have underlying MHE. Among cirrhotic group, Hp infection was present in 28 with MHE (50.9%) vs. in 15 without MHE (42.8%) (p = 0.45). Similarly, SIBO was present in 17 (30.9%) vs. 11 (31.4%) (p = 0.95) in patients with and without MHE respectively. In comparison with healthy controls, patients with cirrhosis were more frequently harboring Hp and SIBO (47.7% vs. 17.7% (p < 0.001) and 31.1% vs. 4.4% (p < 0.001) respectively. On follow-up, all patients showed evidence of eradication of Hp and SIBO infection. Treatment of SIBO significantly improved the state of MHE in cirrhotics, however eradication of Hp infection did not improve MHE significantly. Additionally, patients with low Model for End-Stage Liver Disease (MELD) score and belonging to Child class B had significantly better improvement in MHE. A large number of patients with cirrhosis had either active Hp infection or SIBO with or without MHE, compared to healthy controls. Treatment of SIBO significantly improved MHE in patients with cirrhosis, whereas eradication of Hp did not affect the outcome of MHE in these patients.
format Online
Article
Text
id pubmed-7308324
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73083242020-06-23 Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes Abid, Shahab Kamran, Muhammad Abid, Adeel Butt, Nazish Awan, Safia Abbas, Zaigham Sci Rep Article The effect Helicobacter pylori (Hp) infection and small intestinal bacterial over growth (SIBO) in minimal hepatic encephalopathy (MHE) is not well understood. The aim of the study was to determine the effect of eradication of Hp infection and SIBO treatment on MHE in patients with cirrhosis. Patients with cirrhosis were enrolled and MHE was determined by psychometric tests and critical flicker frequency analysis. Hp infection and SIBO were assessed by urea breath and Hydrogen breath tests respectively in patients with cirrhosis and in healthy volunteers. Patients with Hp infection and SIBO were given appropriate treatment. At six weeks follow-up, presence of Hp infection, SIBO and MHE status was reassessed. Ninety patients with cirrhosis and equal number of healthy controls were included. 55 (61.1%) patients in the cirrhotic group were diagnosed to have underlying MHE. Among cirrhotic group, Hp infection was present in 28 with MHE (50.9%) vs. in 15 without MHE (42.8%) (p = 0.45). Similarly, SIBO was present in 17 (30.9%) vs. 11 (31.4%) (p = 0.95) in patients with and without MHE respectively. In comparison with healthy controls, patients with cirrhosis were more frequently harboring Hp and SIBO (47.7% vs. 17.7% (p < 0.001) and 31.1% vs. 4.4% (p < 0.001) respectively. On follow-up, all patients showed evidence of eradication of Hp and SIBO infection. Treatment of SIBO significantly improved the state of MHE in cirrhotics, however eradication of Hp infection did not improve MHE significantly. Additionally, patients with low Model for End-Stage Liver Disease (MELD) score and belonging to Child class B had significantly better improvement in MHE. A large number of patients with cirrhosis had either active Hp infection or SIBO with or without MHE, compared to healthy controls. Treatment of SIBO significantly improved MHE in patients with cirrhosis, whereas eradication of Hp did not affect the outcome of MHE in these patients. Nature Publishing Group UK 2020-06-22 /pmc/articles/PMC7308324/ /pubmed/32572109 http://dx.doi.org/10.1038/s41598-020-67171-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Abid, Shahab
Kamran, Muhammad
Abid, Adeel
Butt, Nazish
Awan, Safia
Abbas, Zaigham
Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes
title Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes
title_full Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes
title_fullStr Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes
title_full_unstemmed Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes
title_short Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes
title_sort minimal hepatic encephalopathy: effect of h. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308324/
https://www.ncbi.nlm.nih.gov/pubmed/32572109
http://dx.doi.org/10.1038/s41598-020-67171-7
work_keys_str_mv AT abidshahab minimalhepaticencephalopathyeffectofhpyloriinfectionandsmallintestinalbacterialovergrowthtreatmentonclinicaloutcomes
AT kamranmuhammad minimalhepaticencephalopathyeffectofhpyloriinfectionandsmallintestinalbacterialovergrowthtreatmentonclinicaloutcomes
AT abidadeel minimalhepaticencephalopathyeffectofhpyloriinfectionandsmallintestinalbacterialovergrowthtreatmentonclinicaloutcomes
AT buttnazish minimalhepaticencephalopathyeffectofhpyloriinfectionandsmallintestinalbacterialovergrowthtreatmentonclinicaloutcomes
AT awansafia minimalhepaticencephalopathyeffectofhpyloriinfectionandsmallintestinalbacterialovergrowthtreatmentonclinicaloutcomes
AT abbaszaigham minimalhepaticencephalopathyeffectofhpyloriinfectionandsmallintestinalbacterialovergrowthtreatmentonclinicaloutcomes